Scholarly Index
Biagio Ricciuti
Dana-Farber Cancer Institute; 10,280 total citations; 378 total publications; best world rank #63
Dana-Farber Cancer Institute
10,280Total citations
378Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 463 | US 241 | 98.95 |
| Lung Cancer Treatments and Mutations | Lifetime | 488 | US 237 | 98.92 |
| Lung Cancer Research Studies | Lifetime | 600 | US 260 | 97.91 |
| Cancer Mechanisms and Therapy | Lifetime | 686 | US 274 | 93.70 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 85 | US 28 | 99.67 |
| Cancer Genomics and Diagnostics | 2021-2025 | 84 | US 49 | 99.30 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 63 | US 27 | 99.59 |
| Lung Cancer Research Studies | 2021-2025 | 76 | US 29 | 98.83 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 344 | US 107 | 96.39 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 512 | US 161 | 93.97 |
| Cancer Mechanisms and Therapy | 2021-2025 | 233 | US 32 | 88.11 |
| Melanoma and MAPK Pathways | 2021-2025 | 751 | US 260 | 72.42 |
| Chromatin Remodeling and Cancer | 2021-2025 | 581 | US 242 | 64.15 |